Scientex Bhd (4731)
Bursa Malaysia · Malaysia · prices in MYR · close of 27 Oct 2026
Key indicators
| Last close | MYR 3.570 |
|---|---|
| 52-week range | 3.280 – 4.000 |
| Return, 1 month / 3 months | −3.3% / −3.5% |
| Return, 1 year / 3 years | +4.5% / +8.4% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 23.0% |
| Worst drawdown (1 year) | -16.0% |
| Average daily value traded | 2.85M MYR |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Scientex is a Malaysian manufacturer of flexible plastic packaging, producing films, bags and related packaging materials for food, beverage and consumer goods customers. The company also operates a property development business that builds affordable homes and residential townships in Malaysia. Its packaging products serve industrial and consumer markets, while its property arm focuses on buyers seeking entry-level housing. Scientex is based in Malaysia and runs manufacturing and development operations across the country.
On this site Scientex Bhd appears as a stock on the Bursa Malaysia (Malaysia), code 4731, with prices in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Scientex Bhd (4731) trades on the Bursa Malaysia in Malaysia. It last closed at MYR 3.570 on 27 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 171 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.5% and over the last three months it fell 3.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Bursa Malaysia
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.1% | ||
| From 52-week high | -10.5% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.5% | ||
| 6-month return | -2.2% | ||
| 12-month return, skipping the last month | 8.0% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.0% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 2.85M MYR | ||
| Zero-volume days | 5.0% | ||
| Income | 52 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.8% |
|---|---|
| 1 month | −3.3% |
| 3 months | −3.5% |
| 6 months | −2.2% |
| 1 year | +4.5% |
| 3 years | +8.4% |
| 5 years | −10.0% |
Signals
| 50-day / 200-day average | 3.683 / 3.646 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.070 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Jun 2026 | MYR 0.0600 |
| 7 Jan 2026 | MYR 0.0600 |
| 7 Jul 2025 | MYR 0.0600 |
| 7 Jan 2025 | MYR 0.0600 |
| 9 Jul 2024 | MYR 0.0600 |
| 2 Jan 2024 | MYR 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Bursa Malaysia; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.